dihydrotachysterol and Bone-Diseases

dihydrotachysterol has been researched along with Bone-Diseases* in 16 studies

Reviews

1 review(s) available for dihydrotachysterol and Bone-Diseases

ArticleYear
Editorial: Vitamin D, the kidney and calcium homeostasis.
    Kidney international, 1972, Volume: 2, Issue:5

    Topics: Bone and Bones; Bone Diseases; Calcium; Cholecalciferol; Dihydrotachysterol; Homeostasis; Intestinal Absorption; Kidney; Kidney Failure, Chronic; Uremia; Vitamin D

1972

Other Studies

15 other study(ies) available for dihydrotachysterol and Bone-Diseases

ArticleYear
Effects of new analogues of vitamin D on bone cells: implications for treatment of uremic bone disease.
    Kidney international, 1999, Volume: 55, Issue:2

    The use of calcitriol in the treatment of uremic hyperparathyroidism and renal osteodystrophy is limited in many patients by hypercalcemic side-effects. New less calcemic analogues of calcitriol are being developed, and some are under clinical evaluation. To investigate whether these compounds possess important differences in their action on bone cells, we have studied their effects [with and without parathyroid hormone (PTH)] on the release and synthesis of the resorptive osteotropic cytokine, interleukin-6 (IL-6).. MG 63 and SaOS-2 human osteoblastic cell lines were cultured for 6 or 24 hours in media containing calcitriol, the sterols of interest, or 1-34 synthetic PTH. IL-6 release was assayed by commercially available enzyme-linked immunosorbent assay. IL-6 mRNA levels were assessed by reverse transcriptase-polymerase chain reaction.. We found that calcitriol and paricalcitol behaved in a similar fashion, resulting in increased IL-6 release only at higher concentrations (10(-7) to 10(-9) M). In contrast, 22-oxacalcitriol and 1,25-dihydroxydihydrotachysterol2 stimulated release to a similar extent but at concentrations three to four orders of magnitude lower (10(-11) to 10(-13) M), despite being less potent as suppressers of parathyroid function than calcitriol. Studies of IL-6 mRNA showed a similar pattern of concentration and cell line-dependent transcription.. Compounds stimulating IL-6 release at concentrations achievable during the treatment of uremic hyperparathyroidism might favor continuing linked bone formation and resorption and thereby avoid adynamic bone disease while still allowing profound suppression of PTH.

    Topics: Bone Diseases; Calcitriol; Cell Line; Dihydrotachysterol; Ergocalciferols; Humans; Interleukin-1; Osteoblasts; Parathyroid Hormone; RNA, Messenger; Uremia; Vitamin D

1999
Dihydrotachysterol and calcitriol in long-term dialyzed patients with renal bone disease.
    Acta Universitatis Carolinae. Medica, 1986, Volume: 32, Issue:5-6

    Topics: Bone Diseases; Calcitriol; Dihydrotachysterol; Humans; Kidney Failure, Chronic; Renal Dialysis

1986
Bone deficit in ovariectomized rats. Functional contribution of the marrow stromal cell population and the effect of oral dihydrotachysterol treatment.
    The Journal of clinical investigation, 1986, Volume: 78, Issue:3

    This study investigates the proliferative and osteogenic role of marrow stromal/osteoprogenitor cells in the development of the cortical bone deficit in ovariectomized (OVX) female rats. In vitro, clonal growth of marrow stromal cells from OVX rats was significantly impaired (vs. sham-operated controls). Yet in vivo, cells from sham-operated and OVX rats had equal osteogenic potential in several in vivo experimental situations, such as in intraperitoneally implanted millipore diffusion chambers and in intramuscular implants of marrow plus osteoinductive bone matrix (composite grafts). Long-term (6 mo) dihydrotachysterol (DHT) treatment of OVX rats enhanced their in vitro proliferative potential and clonal growth, as well as their osteogenic expression in composite grafts. The observation that the in vivo osteogenic performance of OVX rat marrow stromal cells was normal at extraosseous sites suggests that the mechanisms leading to osteopenia may involve an abnormality in cell-matrix interactions.

    Topics: Animals; Bone Diseases; Bone Marrow; Bone Marrow Transplantation; Bone Matrix; Cell Division; Cells, Cultured; Dihydrotachysterol; Disease Models, Animal; Female; Fibroblasts; Minerals; Osteogenesis; Ovariectomy; Rats; Rats, Inbred Strains; Stem Cells

1986
Neonatal primary hyperparathyroidism with autosomal dominant inheritance.
    The Journal of pediatrics, 1977, Volume: 90, Issue:2

    Topics: Bone Diseases; Calcium; Dihydrotachysterol; Female; Genes, Dominant; Humans; Hypercalcemia; Hyperparathyroidism; Infant, Newborn; Infant, Newborn, Diseases; Parathyroid Glands; Pedigree

1977
Fibrogenesis imperfecta ossium.
    The Quarterly journal of medicine, 1976, Volume: 45, Issue:178

    The case history, clinical course and laboratory findings in a 66-year-old woman with fibrogenesis imperfecta ossium are reported, the sixth case in the literature. The condition is characterized clinically by intractable skeletal pain and progressive immobility. Though serum alkaline phosphatase has been raised in all patients, there are no specific haematological or biochemical findings. The radiological features of coarse and dense trabecular pattern with symmetrical and diffuse involvement of all bones without expansion or change of shape, together with periosteal reactions and soft tissue calcification are characteristic. The macroscopic appearance of bone shows large areas of opaque white and brittle trabeculae. The histological findings mimic those of osteomalacia unless examined under polarized light which shows the loss of normal birefringence. On electron microscopy the normal lamellar pattern made up of orientated collagen fibrils all about 80 nm diameter is replaced by a random tangled pattern of much thinner irregularly curved fibrils, some as thin as 5nm. The condition appears to be acquired, leading to erosion of the normal skeleton and replacement with an abnormal fibre deficient matrix. There is no definitive therapy at present.

    Topics: Aged; Alkaline Phosphatase; Autopsy; Bone Diseases; Bone Matrix; Calcium; Collagen; Dihydrotachysterol; Ergocalciferols; Humans; Male; Radiography; Skin

1976
[Calcification disorders of the skeleton].
    Der Internist, 1975, Volume: 16, Issue:8

    Topics: Bone and Bones; Bone Diseases; Calcium Metabolism Disorders; Dihydrotachysterol; Humans; Osteomalacia; Vitamin D

1975
[Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    MMW, Munchener medizinische Wochenschrift, 1974, Sep-13, Volume: 116, Issue:37

    Topics: Animals; Bone Diseases; Calcium; Chemical Phenomena; Chemistry; Cholecalciferol; Dihydrotachysterol; Dihydroxycholecalciferols; Disease Models, Animal; Humans; Hydroxycholecalciferols; Isomerism; Kidney Failure, Chronic; Microradiography; Osteitis Fibrosa Cystica; Osteomalacia; Phosphates; Rats; Renal Dialysis; Uremia; Vitamin D

1974
Proceedings: Dihydrotachysterol in the treatment of bone abnormality in patients with renal failure undergoing chronic hemodialysis.
    Calcified tissue research, 1974, Volume: 15, Issue:2

    Topics: Bone Diseases; Dihydrotachysterol; Humans; Kidney Failure, Chronic; Renal Dialysis; Uremia

1974
[Partial parathyroidectomy in the treatment of metastatic calcareous infiltration (case report of a patient with chronic hemodialysis therapy)].
    Der Internist, 1972, Volume: 13, Issue:2

    Topics: Arm; Bone Diseases; Calcinosis; Calcium; Calcium Carbonate; Dihydrotachysterol; Hand; Hip Joint; Humans; Hyperparathyroidism; Leg; Male; Middle Aged; Parathyroid Glands; Phosphorus; Radiography; Renal Dialysis

1972
[Hyperparathyroidism].
    Naika. Internal medicine, 1971, Volume: 27, Issue:6

    Topics: Adult; Bone Diseases; Calcium; Dihydrotachysterol; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hypokalemia; Lactates; Male; Middle Aged; Polyuria; Prednisolone; Sodium; Sulfates; Urinary Calculi

1971
Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Transactions of the Association of American Physicians, 1970, Volume: 83

    Topics: Absorption; Adolescent; Adult; Autoanalysis; Biopsy; Bone Diseases; Calcium; Calcium Isotopes; Dihydrotachysterol; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Time Factors; Vitamin D

1970
[Electron microscopic findings in experimental periosteocytic decalcification due to dihydrotachysterol].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1967, Volume: 51

    Topics: Animals; Bone Diseases; Calcium Metabolism Disorders; Decalcification, Pathologic; Dihydrotachysterol; Femur; Microscopy, Electron; Osteocytes; Rats

1967
Fibrogenesis imperfecta ossium.
    The Journal of bone and joint surgery. British volume, 1966, Volume: 48, Issue:4

    Topics: Bone Diseases; Collagen Diseases; Dihydrotachysterol; Humans; Male; Middle Aged; Radiography; Vitamin D

1966
HYPERPARATHYROIDISM.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Adenoma; Antacids; Back Pain; Biopsy; Bone Diseases; Calcinosis; Calcium; Diagnosis; Dihydrotachysterol; Humans; Hyperparathyroidism; Mandible; Parathyroid Neoplasms; Pathology; Radiography, Dental; Surgical Procedures, Operative; Tibia

1964
[Induction of fibrous osteodystrophy by calciphylaxis].
    Beitrage zur pathologischen Anatomie und zur allgemeinen Pathologie, 1961, Volume: 125

    Topics: Bone Diseases; Calciphylaxis; Calcium; Dihydrotachysterol; Osteitis Fibrosa Cystica; Water-Electrolyte Balance

1961